Related references
Note: Only part of the references are listed.A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation
Mikal Jacob Hole et al.
HEPATOLOGY (2023)
Bile from Patients with Primary Sclerosing Cholangitis Contains Mucosal-Associated Invariant T-Cell Antigens
Laura Valestrand et al.
AMERICAN JOURNAL OF PATHOLOGY (2022)
Aberrant hepatic trafficking of gut-derived T cells is not specific to primary sclerosing cholangitis
Jonathon J. Graham et al.
HEPATOLOGY (2022)
Diet and gut microbiome in gastrointestinal disease
Gina L. Trakman et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)
Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort
Youwen Qin et al.
NATURE GENETICS (2022)
Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project
Esteban A. Lopera-Maya et al.
NATURE GENETICS (2022)
Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
Claudia D. Fuchs et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)
A Parallel Tracking of Salivary and Gut Microbiota Profiles Can Reveal Maturation and Interplay of Early Life Microbial Communities in Healthy Infants
Sofia Reddel et al.
MICROORGANISMS (2022)
Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis
Qiaoyan Liu et al.
GUT (2022)
Small Intestinal Bacterial Overgrowth-Pathophysiology and Its Implications for Definition and Management
Daniel Bushyhead et al.
GASTROENTEROLOGY (2022)
Gut-derived systemic inflammation as a driver of depression in chronic liver disease
Victoria T. Kronsten et al.
JOURNAL OF HEPATOLOGY (2022)
Dietary management of adults with IBD - the emerging role of dietary therapy
Jessica A. Fitzpatrick et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)
MAIT cells in liver inflammation and fibrosis
Hema Mehta et al.
SEMINARS IN IMMUNOPATHOLOGY (2022)
Structure and function of non-digestible carbohydrates in the gut microbiome
R. A. Rastall et al.
BENEFICIAL MICROBES (2022)
Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer
Yongyan Chen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells
L. Valestrand et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)
Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis
Mark R. Deneau et al.
HEPATOLOGY (2021)
Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis
Y. Lapidot et al.
HEPATOLOGY INTERNATIONAL (2021)
Gut microbial metabolites as multi-kingdom intermediates
Kimberly A. Krautkramer et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Autism-related dietary preferences mediate autism-gut microbiome associations
Chloe X. Yap et al.
CELL (2021)
Sweet death: Fructose as a metabolic toxin that targets the gut-liver axis
Mark A. Febbraio et al.
CELL METABOLISM (2021)
Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis
Martin Kummen et al.
GASTROENTEROLOGY (2021)
Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease
Chathur Acharya et al.
GASTROENTEROLOGY (2021)
Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases
Iliyan D. Iliev et al.
GASTROENTEROLOGY (2021)
Genome-wide association study in 8,956 German individuals identifies influence of ABO histo-blood groups on gut microbiome
Malte Christoph Ruehlemann et al.
NATURE GENETICS (2021)
Associations of neopterin and kynurenine-tryptophan ratio with survival in primary sclerosing cholangitis
Amandeep Kaur Dhillon et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)
Reduced immune-regulatory molecule expression on human colonic memory CD4 T cells in older adults
Stephanie M. Dillon et al.
IMMUNITY & AGEING (2021)
Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis
Lars Bossen et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2021)
Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides
Montserrat Puig et al.
FRONTIERS IN IMMUNOLOGY (2021)
Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis
Ratika Sehgal et al.
NUTRIENTS (2021)
Clinical Features and Outcomes of Primary Sclerosing Cholangitis in the Highly Admixed Brazilian Population
Mateus Jorge Nardelli et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Bile Acid Receptors and the Gut-Liver Axis in Nonalcoholic Fatty Liver Disease
Rui Xue et al.
CELLS (2021)
The Gut-Liver Axis in Chronic Liver Disease: A Macrophage Perspective
Kevin De Muynck et al.
CELLS (2021)
Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4+ T cells in primary sclerosing cholangitis
Tobias Poch et al.
JOURNAL OF HEPATOLOGY (2021)
Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis
Maria Reich et al.
JOURNAL OF HEPATOLOGY (2021)
Intestinal CD8+ T cell responses are abundantly induced early in human development but show impaired cytotoxic effector capacities
R. R. C. E. Schreurs et al.
MUCOSAL IMMUNOLOGY (2021)
MAIT cells, guardians of skin and mucosa?
Isabelle Nel et al.
MUCOSAL IMMUNOLOGY (2021)
Fecal Microbiota Transplantation as Therapy for Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
Xiaolei Liu et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2021)
Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages via RIP3 Signaling Pathway in Autoimmune Hepatitis
Hongxia Zhang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Bile Microbiota in Liver Transplantation: Proof of Concept Using Gene Amplification in a Heterogeneous Clinical Scenario
Francesco D'Amico et al.
FRONTIERS IN SURGERY (2021)
Nuclear receptors in liver fibrosis
Philipp Koenigshofer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)
Intestinal virome and therapeutic potential of bacteriophages in liver disease
Cynthia L. Hsu et al.
JOURNAL OF HEPATOLOGY (2021)
Dark and bright side of targeting fibroblast growth factor receptor 4 in the liver
Raffaella Maria Gadaleta et al.
JOURNAL OF HEPATOLOGY (2021)
A biliary immune landscape map of primary sclerosing cholangitis reveals a dominant network of neutrophils and tissue-resident T cells
Christine L. Zimmer et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
The gut vascular barrier: a new player in the gut-liver-brain axis
Paola Brescia et al.
TRENDS IN MOLECULAR MEDICINE (2021)
Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease
Eleni Rebelos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy
Amber G. Bozward et al.
FRONTIERS IN IMMUNOLOGY (2021)
Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis
Fiorella D'Onofrio et al.
CELLS (2021)
Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling
Kai Markus Schneider et al.
NATURE METABOLISM (2021)
Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis
Bo Li et al.
GUT MICROBES (2021)
Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast Cancer
Samitha Andrahennadi et al.
CURRENT ONCOLOGY (2021)
Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review
Kate Gallagher et al.
JOURNAL OF CROHNS & COLITIS (2021)
Gut dysbiosis as a driver in alcohol-induced liver injury
Bradley Fairfield et al.
JHEP REPORTS (2021)
Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis
Ewa Wunsch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis
Weihua Chen et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
Kate D. Lynch et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis
Sara Lemoinne et al.
GUT (2020)
Alterations of gut microbiome in autoimmune hepatitis
Yiran Wei et al.
GUT (2020)
Alterations of the bile microbiome in primary sclerosing cholangitis
Timur Liwinski et al.
GUT (2020)
Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species
Malte Christoph Ruehlemann et al.
GUT (2020)
Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience
Ming-Hsi Wang et al.
INFLAMMATORY BOWEL DISEASES (2020)
The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease
Huikuan Chu et al.
JOURNAL OF HEPATOLOGY (2020)
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Agustin Albillos et al.
JOURNAL OF HEPATOLOGY (2020)
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis
Charlotte Rose Hawkey Hedin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review
Rapat Pittayanon et al.
GASTROENTEROLOGY (2020)
Monocytes as Potential Mediators of Pathogen-Induced T-Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC)
Lilly Kristin Kunzmann et al.
HEPATOLOGY (2020)
Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes
Matthew Peverelle et al.
INFLAMMATORY BOWEL DISEASES (2020)
A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways
Mohammed Nabil Quraishi et al.
JOURNAL OF CROHNS & COLITIS (2020)
Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis
Jasmohan S. Bajaj et al.
JOURNAL OF HEPATOLOGY (2020)
A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis
Timur Liwinski et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Interaction between microbiota and immunity in health and disease
Danping Zheng et al.
CELL RESEARCH (2020)
Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age
Palak J. Trivedi et al.
GASTROENTEROLOGY (2020)
Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis
Masanori Furukawa et al.
HEPATOLOGY RESEARCH (2020)
The liver as an immunological barrier redefined by single-cell analysis
Zania Stamataki et al.
IMMUNOLOGY (2020)
Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities
Mette Vesterhus et al.
JOURNAL OF GASTROENTEROLOGY (2020)
A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
Kris Kowdley et al.
JOURNAL OF HEPATOLOGY (2020)
Paneth cells promote angiogenesis and regulate portal hypertension in response to microbial signals
Mohsin Hassan et al.
JOURNAL OF HEPATOLOGY (2020)
Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease
Zhangran Chen et al.
FRONTIERS IN MICROBIOLOGY (2020)
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron-Wisnewsky et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals
Jiamin Lou et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium
Trevor J. Laborda et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2020)
Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis
Ahmad Hassan Ali et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2020)
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis
Emma L. Culver et al.
LIVER INTERNATIONAL (2020)
Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma
Elsemieke de Vries et al.
LIVER INTERNATIONAL (2020)
Understanding the impact of antibiotic perturbation on the human microbiome
D. J. Schwartz et al.
GENOME MEDICINE (2020)
Bifidobacterium animalisssp. Lactis 420 Mitigates Autoimmune Hepatitis Through Regulating Intestinal Barrier and Liver Immune Cells
Hongxia Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Host variables confound gut microbiota studies of human disease
Ivan Vujkovic-Cvijin et al.
NATURE (2020)
Altered Microbiome in Patients With Cirrhosis and Complications
Chathur Acharya et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis-ulcerative colitis
Li-Zsa Tan et al.
GUT (2019)
Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
Amandeep K. Dhillon et al.
LIVER INTERNATIONAL (2019)
Hepatic Manifestations of Cystic Fibrosis
Sasan Sakiani et al.
CLINICS IN LIVER DISEASE (2019)
Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
Lijun Liao et al.
GUT (2019)
Oral Vancomycin Induces and Maintains Remission of Ulcerative Colitis in the Subset of Patients With Associated Primary Sclerosing Cholangitis
Alexander Dao et al.
INFLAMMATORY BOWEL DISEASES (2019)
Cholangiocyte pathobiology
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Tissue-resident Eomes+ NK cells are the major innate lymphoid cell population in human infant intestine
Adrian F. Sagebiel et al.
NATURE COMMUNICATIONS (2019)
Leaky gut: mechanisms, measurement and clinical implications in humans
Michael Camilleri
GUT (2019)
Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study
Benedicte Caron et al.
JOURNAL OF CROHNS & COLITIS (2019)
Early TIPS with covered stent versus standard treatment for acute variceal bleeding among patients with advanced cirrhosis: A randomised controlled trial
Yong Lv et al.
JOURNAL OF HEPATOLOGY (2019)
Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections
Nicola Principi et al.
FRONTIERS IN PHARMACOLOGY (2019)
Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease
Almut Heinken et al.
MICROBIOME (2019)
Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis
Malte Ruehlemann et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Model of personalized postprandial glycemic response to food developed for an Israeli cohort predicts responses in Midwestern American individuals
Helena Mendes-Soares et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2019)
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
Clara Depommier et al.
NATURE MEDICINE (2019)
Microbial genes and pathways in inflammatory bowel disease
Melanie Schirmer et al.
NATURE REVIEWS MICROBIOLOGY (2019)
The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile
Natalia Molinero et al.
MICROBIOME (2019)
Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses
Sara Vieira-Silva et al.
NATURE MICROBIOLOGY (2019)
Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease
Xiaojun Zhuang et al.
INFLAMMATORY BOWEL DISEASES (2019)
Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease
Yiwen Zhang et al.
BMC GENOMICS (2019)
Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
Yi Duan et al.
NATURE (2019)
Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis
Knut Stokkeland et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis A Randomized Clinical Trial
Samuel P. Costello et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
Gideon M. Hirschfield et al.
JOURNAL OF HEPATOLOGY (2019)
Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis
Nobuhiro Nakamoto et al.
NATURE MICROBIOLOGY (2019)
Gut microbiome structure and metabolic activity in inflammatory bowel disease
Eric A. Franzosa et al.
NATURE MICROBIOLOGY (2019)
Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation
Iris C. Steenstraten et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial
Jessica R. Allegretti et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis
Byron P. Vaughn et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2019)
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease
Floris Imhann et al.
GUT (2018)
Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy
Ruqi Tang et al.
GUT (2018)
Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner
Palak J. Trivedi et al.
GUT (2018)
Dissecting human ILC heterogeneity: more than just three subsets
Yannick Simoni et al.
IMMUNOLOGY (2018)
Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011
Jakob Orskov Sorensen et al.
LIVER INTERNATIONAL (2018)
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Wei Jia et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease
J. Torres et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease
B. Christensen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease
C. S. Tse et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis
P. J. Trivedi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Allison Agus et al.
CELL HOST & MICROBE (2018)
Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon
Noa Krugliak Cleveland et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease
Shailja C. Shah et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series
Romain Altwegg et al.
DIGESTIVE AND LIVER DISEASE (2018)
Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease
Dana Tedesco et al.
GASTROENTEROLOGY (2018)
Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis
Cyriel Y. Ponsioen et al.
HEPATOLOGY (2018)
Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
Preeti Pathak et al.
HEPATOLOGY (2018)
Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis
Mohamad A. Mouchli et al.
INFLAMMATORY BOWEL DISEASES (2018)
Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts
Martin Kummen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease
Kazumichi Abe et al.
PLOS ONE (2018)
Do Long-Lived Plasma Cells Maintain a Healthy Microbiota in the Gut?
Frode L. Jahnsen et al.
TRENDS IN IMMUNOLOGY (2018)
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis
Tamas Tornai et al.
SCIENTIFIC REPORTS (2018)
Dysbiosis of the salivary microbiota in pediatric-onset primary sclerosing cholangitis and its potential as a biomarker
Kentaro Iwasawa et al.
SCIENTIFIC REPORTS (2018)
5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
Jun Xu et al.
FRONTIERS IN MICROBIOLOGY (2018)
Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome
Jane M. Natividad et al.
CELL METABOLISM (2018)
Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis
Guillaume Pineton de Chambrun et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Primary sclerosing cholangitis leads to dysfunction and loss of MAIT cells
Erik von Seth et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Natural killer T cells mediate inflammation in the bile ducts
N. L. Berntsen et al.
MUCOSAL IMMUNOLOGY (2018)
Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis
Samer Al-Dury et al.
SCIENTIFIC REPORTS (2018)
Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype
Mandy Sowa et al.
FRONTIERS IN IMMUNOLOGY (2018)
Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1
Ara Koh et al.
CELL (2018)
FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid
Elliot S. Friedman et al.
GASTROENTEROLOGY (2018)
Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis
Pamela S. Tietz-Bogert et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Origin, Differentiation, and Function of Intestinal Macrophages
Calum C. Bain et al.
FRONTIERS IN IMMUNOLOGY (2018)
Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients
C. Nordenvall et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease
Brian K. Chung et al.
HEPATOLOGY COMMUNICATIONS (2018)
Diet-Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice
Dominique Debray et al.
HEPATOLOGY COMMUNICATIONS (2018)
The gut-adherent microbiota of PSC-IBD is distinct to that of IBD
Mohammed Nabil Quraishi et al.
GUT (2017)
Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis
Kentaro Iwasawa et al.
GUT (2017)
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
Martin Kummen et al.
GUT (2017)
Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis
Sebastian Torben Jendrek et al.
GUT (2017)
Fungal microbiota dysbiosis in IBD
Harry Sokol et al.
GUT (2017)
Low-Grade Endotoxemia and Platelet Activation in Cirrhosis
Valeria Raparelli et al.
HEPATOLOGY (2017)
Short- and long-term effects of oral vancomycin on the human intestinal microbiota
Sandrine Isaac et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis
Takeji Umemura et al.
LIVER INTERNATIONAL (2017)
Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis
Johannes R. Hov et al.
LIVER INTERNATIONAL (2017)
Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease
Sun-Gou Ji et al.
NATURE GENETICS (2017)
Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function
Martin Kummen et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases
Susanna Nikolaus et al.
GASTROENTEROLOGY (2017)
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
Tobias J. Weismueller et al.
GASTROENTEROLOGY (2017)
Validation of the Prognostic Value of Histologic Scoring Systems in Primary Sclerosing Cholangitis: An International Cohort Study
Elisabeth M. G. de Vries et al.
HEPATOLOGY (2017)
Regionalized Development and Maintenance of the Intestinal Adaptive Immune Landscape
William W. Agace et al.
IMMUNITY (2017)
Tissue adaptation: Implications for gut immunity and tolerance
Ana M. C. Faria et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
Peter Fickert et al.
JOURNAL OF HEPATOLOGY (2017)
Primary sclerosing cholangitis - a comprehensive review
Tom H. Karlsen et al.
JOURNAL OF HEPATOLOGY (2017)
Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease
Eva Kristine Klemsdal Henriksen et al.
JOURNAL OF HEPATOLOGY (2017)
The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation
Elisabeth Schrumpf et al.
JOURNAL OF HEPATOLOGY (2017)
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study
Vinod S. Hegade et al.
LANCET (2017)
Genetics of primary sclerosing cholangitis and pathophysiological implications
Xiaojun Jiang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
Lukas Bajer et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
A Murine Intestinal Intraepithelial NKp46-Negative Innate Lymphoid Cell Population Characterized by Group 1 Properties
Aline Van Acker et al.
CELL REPORTS (2017)
Innate Lymphoid Cells in Intestinal Inflammation
Alessandra Geremia et al.
FRONTIERS IN IMMUNOLOGY (2017)
Differential Location and Distribution of Hepatic Immune Cells
Maria Alice Freitas-Lopes et al.
CELLS (2017)
Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia
Pedro Pereira et al.
PLOS ONE (2017)
Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid Receptor Signalling
Annika Wahlstrom et al.
DIGESTIVE DISEASES (2017)
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition
Ruud S. Kootte et al.
CELL METABOLISM (2017)
Immunosuppressive Agents for the Treatment of Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis
Xia Peng et al.
DIGESTIVE DISEASES (2017)
Resolution of inflammation in inflammatory bowel disease
Gerhard Rogler
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases
Ashwin N. Ananthakrishnan et al.
CELL HOST & MICROBE (2017)
Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes
Eliana Marino et al.
NATURE IMMUNOLOGY (2017)
Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis
James H. Tabibian et al.
AMERICAN JOURNAL OF THERAPEUTICS (2017)
TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro
Maria Reich et al.
GUT (2016)
The composition and differentiation potential of the duodenal intraepithelial innate lymphocyte compartment is altered in coeliac disease
Frederike Schmitz et al.
GUT (2016)
Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
James H. Tabibian et al.
HEPATOLOGY (2016)
Surrogate Endpoints for Clinical Trials in Primary Sclerosing Cholangitis: Review and Results From an International PSC Study Group Consensus Process
Cyriel Y. Ponsioen et al.
HEPATOLOGY (2016)
Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis
D. Kevans et al.
JOURNAL OF CROHNS & COLITIS (2016)
The features of mucosa-associated microbiota in primary sclerosing cholangitis
J. Torres et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis
Long-Xian Lv et al.
ENVIRONMENTAL MICROBIOLOGY (2016)
Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options
Irene Franceschet et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease
Aida Kapic Lunder et al.
GASTROENTEROLOGY (2016)
Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
Joao Sabino et al.
GUT (2016)
Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity
Palak J. Trivedi et al.
JOURNAL OF AUTOIMMUNITY (2016)
Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition
Maria K. Magnusson et al.
JOURNAL OF CROHNS & COLITIS (2016)
Coffee consumption protects against progression in liver cirrhosis and increases long-term survival after liver transplantation
Kilian Friedrich et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: a Pilot Study
Shahab Rahimpour et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2016)
Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation
S. F. Jorgensen et al.
MUCOSAL IMMUNOLOGY (2016)
Human gut microbes impact host serum metabolome and insulin sensitivity
Helle Krogh Pedersen et al.
NATURE (2016)
Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota
Jun Wang et al.
NATURE GENETICS (2016)
CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands
Bruno Lamas et al.
NATURE MEDICINE (2016)
Immunological aspects of intestinal mucus and mucins
Malin E. V. Johansson et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Gut microbiota diversity predicts immune status in HIV-1 infection
Piotr Nowak et al.
AIDS (2015)
Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation
Kaija-Leena Kolho et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Personalized Nutrition by Prediction of Glycemic Responses
David Zeevi et al.
CELL (2015)
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis
Zeneng Wang et al.
CELL (2015)
The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
Aleksandar D. Kostic et al.
CELL HOST & MICROBE (2015)
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
Paul Moayyedi et al.
GASTROENTEROLOGY (2015)
The biliary epithelium presents antigens to and activates natural killer T cells
Elisabeth Schrumpf et al.
HEPATOLOGY (2015)
Interleukin-12 and-23 Control Plasticity of CD127+ Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria
Jochem H. Bernink et al.
IMMUNITY (2015)
Methods to determine intestinal permeability and bacterial translocation during liver disease
Lirui Wang et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
A gut-vascular barrier controls the systemic dissemination of bacteria
Ilaria Spadoni et al.
SCIENCE (2015)
Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes
Stefania Magnusdottir et al.
FRONTIERS IN GENETICS (2015)
Dietary effects on human gut microbiome diversity
Zhenjiang Xu et al.
BRITISH JOURNAL OF NUTRITION (2015)
The Mucosa-associated Microbiota of PSC Patients is Characterized by Low Diversity and Low Abundance of Uncultured Clostridiales II
Noortje G. Rossen et al.
JOURNAL OF CROHNS & COLITIS (2015)
Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis
Lauren N. Bell et al.
LIVER INTERNATIONAL (2015)
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
Hiroshi Fukui
WORLD JOURNAL OF HEPATOLOGY (2015)
Immunoglobulin A Coating Identifies Colitogenic Bacteria in Inflammatory Bowel Disease
Noah W. Palm et al.
CELL (2014)
The Treatment-Naive Microbiome in New-Onset Crohn's Disease
Dirk Gevers et al.
CELL HOST & MICROBE (2014)
Effects of Coffee Consumption, Smoking, and Hormones on Risk for Primary Sclerosing Cholangitis
Ina Marie Andersen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Reduced Coffee Consumption Among Individuals With Primary Sclerosing Cholangitis but Not Primary Biliary Cirrhosis
Craig Lammert et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan
Atsushi Tanaka et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2014)
Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity
Anne Vrieze et al.
JOURNAL OF HEPATOLOGY (2014)
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Jasmohan S. Bajaj et al.
JOURNAL OF HEPATOLOGY (2014)
Diet rapidly and reproducibly alters the human gut microbiome
Lawrence A. David et al.
NATURE (2014)
Protective mucosal immunity mediated by epithelial CD1d and IL-10
Torsten Olszak et al.
NATURE (2014)
Alterations of the human gut microbiome in liver cirrhosis
Nan Qin et al.
NATURE (2014)
Bile acid receptors as targets for drug development
Frank G. Schaap et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study
J. H. Tabibian et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach
Xiao Wei et al.
BMC GASTROENTEROLOGY (2013)
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
Sama I. Sayin et al.
CELL METABOLISM (2013)
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
Henri Duboc et al.
GUT (2013)
Population-Based Epidemiology, Malignancy Risk, and Outcome of Primary Sclerosing Cholangitis
Kirsten Boonstra et al.
HEPATOLOGY (2013)
Increased T Helper Type 17 Response To Pathogen Stimulation in Patients With Primary Sclerosing Cholangitis
Janosch Katt et al.
HEPATOLOGY (2013)
Immunomodulatory Effect of Vancomycin on Treg in Pediatric Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
David N. Abarbanel et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
Genta Kakiyama et al.
JOURNAL OF HEPATOLOGY (2013)
Dietary vitamin B6 intake modulates colonic inflammation in the IL10-/- model of inflammatory bowel disease
Jacob Selhub et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications
Pablo Bellot et al.
LIVER INTERNATIONAL (2013)
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Shin Yoshimoto et al.
NATURE (2013)
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
Jimmy Z. Liu et al.
NATURE GENETICS (2013)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Vanessa K. Ridaura et al.
SCIENCE (2013)
Progressive Primary Sclerosing Cholangitis Requiring Liver Transplantation Is Associated With Reduced Need for Colectomy in Patients With Ulcerative Colitis
Udayakumar Navaneethan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study
Jocelyn Trottier et al.
DIGESTIVE AND LIVER DISEASE (2012)
Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients
Kristin Kaasen Jorgensen et al.
INFLAMMATORY BOWEL DISEASES (2012)
Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci
Trine Folseraas et al.
JOURNAL OF HEPATOLOGY (2012)
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice
Suzanne Devkota et al.
NATURE (2012)
Bile Acids Regulate Cardiovascular Function
Sandeep Khurana et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2011)
Loss of CFTR Affects Biliary Epithelium Innate Immunity and Causes TLR4-NF-κB-Mediated Inflammatory Response in Mice
Romina Fiorotto et al.
GASTROENTEROLOGY (2011)
Immune reactivity to β-tubulin isotype 5 and vesicular integral-membrane protein 36 in patients with autoimmune gastrointestinal disorders
Katrijn Op De Beeck et al.
GUT (2011)
Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
Laura Marelli et al.
GUT (2011)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis
Jingmin Zhao et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Update on primary sclerosing cholangitis
Tom H. Karlsen et al.
DIGESTIVE AND LIVER DISEASE (2010)
Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage
Rita Cariello et al.
DIGESTIVE AND LIVER DISEASE (2010)
Genome-Wide Association Analysis in Primary Sclerosing Cholangitis
Tom H. Karlsen et al.
GASTROENTEROLOGY (2010)
p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ
Birgit Terjung et al.
GUT (2010)
Incidence and Prevalence of Primary Sclerosing Cholangitis in a Defined Adult Population in Sweden
Bjorn Lindkvist et al.
HEPATOLOGY (2010)
Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study
Marina G. Silveira et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis
Liesbet Henckaerts et al.
JOURNAL OF HEPATOLOGY (2009)
Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis
Gerda Rudolph et al.
JOURNAL OF HEPATOLOGY (2009)
Uptake through glycoprotein 2 of FimH+ bacteria by M cells initiates mucosal immune response
Koji Hase et al.
NATURE (2009)
ESSAY What are the consequences of the disappearing human microbiota?
Martin J. Blaser et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Characterization of a Streptococcus sp.-Veillonella sp Community Micromanipulated from Dental Plaque
Natalia I. Chalmers et al.
JOURNAL OF BACTERIOLOGY (2008)
A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis
Daan W. Hommes et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: An immunomodulating antibiotic
Yinka K. Davies et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2008)
Autoantibodies in primary sclerosing cholangitis
Johannes Roksund Hov et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Abnormal intestinal permeability in primary biliary cirrhosis
Jordan J. Feld et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Therapeutic benefit of sulfasalazine for patients with primary sclerosing cholangitis
Shinichiro Tada et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis
P Hruz et al.
GUT (2006)
Primary sclerosing cholangitis, inflammatory a bowel disease, and colon cancer
Ulrika Broome et al.
SEMINARS IN LIVER DISEASE (2006)
Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis
E Björnsson et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2005)
The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis
PCJ ter Borg et al.
BMC GASTROENTEROLOGY (2005)
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
EV Loftus et al.
GUT (2005)
Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis:: A randomized placebo-controlled trial
M Färkkilä et al.
HEPATOLOGY (2004)
A pilot study of etanercept in the treatment of primary sclerosing cholangitis
MP Epstein et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Risk factors for recurrence of primary sclerosing cholangitis of liver allograft
A Vera et al.
LANCET (2002)
Absolute counts and distribution of lymphocyte subsets in small intestine of BALB/c mice change during weaning
M Manzano et al.
JOURNAL OF NUTRITION (2002)
Clinical profile of primary sclerosing cholangitis in Singapore
TL Ang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis
RM Soetikno et al.
GASTROINTESTINAL ENDOSCOPY (2002)
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
A Bergquist et al.
JOURNAL OF HEPATOLOGY (2002)